Duncker Streett & Co’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Duncker Streett & Co’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$19.7K	Hold	300	–	–	﹤0.01%	390
2025 Q1	$21.2K	Hold	300	–	–	﹤0.01%	377
2024 Q4	$19.7K	Hold	300	–	–	﹤0.01%	396
2024 Q3	$21.2K	Hold	300	–	–	﹤0.01%	377
2024 Q2	$19.9K	Hold	300	–	–	﹤0.01%	377
2024 Q1	$20.4K	Hold	300	–	–	﹤0.01%	370
2023 Q4	$18.5K	Hold	300	–	–	﹤0.01%	372
2023 Q3	$17.7K	Hold	300	–	–	﹤0.01%	372
2023 Q2	$17.9K	Hold	300	–	–	﹤0.01%	371
2023 Q1	$17.5K	Hold	300	–	–	﹤0.01%	366
2022 Q4	$18.6K	Hold	300	–	–	﹤0.01%	376
2022 Q3	$17K	Hold	300	–	–	﹤0.01%	366
2022 Q2	$19K	Hold	300	–	–	﹤0.01%	369
2022 Q1	$19K	Hold	300	–	–	﹤0.01%	382
2021 Q4	$20K	Hold	300	–	–	﹤0.01%	413
2021 Q3	$18K	Hold	300	–	–	﹤0.01%	411
2021 Q2	$19K	Hold	300	–	–	﹤0.01%	413
2021 Q1	$18K	Hold	300	–	–	﹤0.01%	409
2020 Q4	$18K	Hold	300	–	–	﹤0.01%	416
2020 Q3	$16K	Hold	300	–	–	﹤0.01%	402
2020 Q2	$15K	Hold	300	–	–	﹤0.01%	413
2020 Q1	$13K	Hold	300	–	–	﹤0.01%	419
2019 Q4	$16K	Buy	+300	New	+$16K	﹤0.01%	441
2019 Q3	–	Sell	-300	Closed	-$15K	–	360
2019 Q2	$15K	Hold	300	–	–	﹤0.01%	462
2019 Q1	$15K	Hold	300	–	–	﹤0.01%	472
2018 Q4	$14K	Hold	300	–	–	﹤0.01%	469
2018 Q3	$17K	Hold	300	–	–	﹤0.01%	473
2018 Q2	$15K	Hold	300	–	–	﹤0.01%	484
2018 Q1	$15K	Hold	300	–	–	﹤0.01%	482
2017 Q4	$15K	Hold	300	–	–	﹤0.01%	483
2017 Q3	$16K	Hold	300	–	–	﹤0.01%	475
2017 Q2	$16K	Hold	300	–	–	0.01%	481
2017 Q1	$15K	Hold	300	–	–	﹤0.01%	500
2016 Q4	$14K	Hold	300	–	–	﹤0.01%	506
2016 Q3	$15K	Hold	300	–	–	0.01%	478
2016 Q2	$14K	Hold	300	–	–	0.01%	485
2016 Q1	$14K	Hold	300	–	–	0.01%	486
2015 Q4	$16K	Hold	300	–	–	0.01%	472
2015 Q3	$15K	Hold	300	–	–	0.01%	477
2015 Q2	$17K	Sell	300 -600	-67%	-$34K	0.01%	479
2015 Q1	$52K	Hold	900	–	–	0.02%	378
2014 Q4	$45K	Hold	900	–	–	0.01%	389
2014 Q3	$42K	Hold	900	–	–	0.01%	395
2014 Q2	$41K	Hold	900	–	–	0.01%	408
2014 Q1	$38K	Hold	900	–	–	0.01%	402
2013 Q4	$35K	Hold	900	–	–	0.01%	396
2013 Q3	$32K	Hold	900	–	–	0.01%	386
2013 Q2	$30K	Buy	+900	New	+$30K	0.01%	393